ScoreWhy is Captor Therapeutics SA ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Poor long term growth as Operating profit has grown by an annual rate -5.88% of over the last 5 years
3
The company has declared negative results in Dec'2024 after 3 consecutive positive quarters
- NET SALES(HY) At PLN 2.01 MM has Grown at -75.97%
- ROCE(HY) Lowest at -109.47%
- RAW MATERIAL COST(Y) Grown by 103% (YoY)
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 111.32%, its profits have risen by 15.4%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Captor Therapeutics SA for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Captor Therapeutics SA
111.32%
0.20
47.86%
Poland WIG
27.62%
1.38
19.95%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
29.28%
EBIT Growth (5y)
-5.88%
EBIT to Interest (avg)
-57.56
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.57
Sales to Capital Employed (avg)
0.26
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.10
EV to EBIT
-3.63
EV to EBITDA
-4.05
EV to Capital Employed
-58.22
EV to Sales
16.26
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-88.12%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
OPERATING CASH FLOW(Y)
Highest at PLN -7.45 MM
NET PROFIT(HY)
Higher at PLN -21.23 MM
-13What is not working for the Company
NET SALES(HY)
At PLN 2.01 MM has Grown at -75.97%
ROCE(HY)
Lowest at -109.47%
RAW MATERIAL COST(Y)
Grown by 103% (YoY
PRE-TAX PROFIT(Q)
Lowest at PLN -11.48 MM
NET PROFIT(Q)
Lowest at PLN -11.48 MM
Here's what is working for Captor Therapeutics SA
Operating Cash Flow
Highest at PLN -7.45 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (PLN MM)
Here's what is not working for Captor Therapeutics SA
Net Sales
At PLN 2.01 MM has Grown at -75.97%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (PLN MM)
Pre-Tax Profit
Lowest at PLN -11.48 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (PLN MM)
Net Profit
Lowest at PLN -11.48 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (PLN MM)
Raw Material Cost
Grown by 103% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
